Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair Randomized Control Trial

NCT05494073 is registered in ClinicalTrials.gov with Henry Ford Health System as lead sponsor.

NCT NCT05494073
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05494073 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anterior Cruciate Ligament Reconstruction Hybrid Remnant Repair Randomized Control Trial
Lead sponsor
Henry Ford Health System
Phase
Not applicable
Overall status
Active, not recruiting
Start date
December 13, 2021
Completion date
November 30, 2026
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior cruciate ligament tear